| 中文名稱:尼羅替尼 | 英文名稱:Nilotinib |
| CAS:641571-10-0 | 品牌: MEDKOO |
| 產(chǎn)地: 國外 | 保存條件: 低溫保存 |
| 純度規(guī)格: >98% | 產(chǎn)品類別: 化學(xué)物質(zhì) |
Name: Nilotinib free base
CAS#: 641571-10-0 (free base)
Chemical Formula: C28H22F3N7O
Exact Mass: 529.1838
Molecular Weight: 529.53
Elemental Analysis: C, 63.51; H, 4.19; F, 10.76; N, 18.52; O, 3.02
Description: Nilotinib, also known as AMN107, is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. Structurally related to imatinib, it was developed based on the structure of the Abl-imatinib complex to address imatinib intolerance and resistance. Nilotinib is a selective Bcr-Abl kinase inhibitor that is 10-30 fold more potent than imatinib in inhibiting Bcr-Abl tyrosine kinase activity and proliferation of Bcr-Abl expressing cells. Nolitinib was developed by Novartis and is sold under the trade name Tasigna.
Synonym: Nilotinib free base; AMN 107; AMN107; AMN-107; Nilotinib; US brand name: Tasigna.
IUPAC/Chemical Name: 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-{(4-(pyridin-3-yl)pyrimidin-2-yl)amino}benzamide
InChi Key: HHZIURLSWUIHRB-UHFFFAOYSA-N
InChi Code: InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)
SMILES Code: O=C(NC1=CC(C(F)(F)F)=CC(N2C=C(C)N=C2)=C1)C3=CC=C(C)C(NC4=NC=CC(C5=CC=CN=C5)=N4)=C3
Appearance: White to off-white solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001

| 成立日期 | 2017-02-16 (10年) | 注冊資本 | 100.000000萬人民幣 |
| 員工人數(shù) | 50-100人 | 年營業(yè)額 | ¥ 500萬-1000萬 |
| 主營行業(yè) | 中間體,催化劑及助劑,生物化工,化學(xué)試劑,儀器耗材 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP13年
|
深圳振強生物技術(shù)有限公司
|
2026-07-29 | |
| 詢價 |
VIP6年
|
成都超九八生物科技有限公司
|
2026-07-29 | |
| 詢價 |
VIP7年
|
上海澤葉生物科技有限公司
|
2026-07-29 | |
| ¥20000 |
VIP13年
|
湖北威德利化學(xué)科技有限公司
|
2026-07-25 | |
| 詢價 |
VIP6年
|
武漢鼎信通藥業(yè)有限公司
|
2026-07-25 | |
| 詢價 |
VIP5年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2026-07-21 | |
| 詢價 |
VIP1年
|
吉林省吉創(chuàng)致遠醫(yī)藥有限公司
|
2026-07-20 | |
| 詢價 |
VIP8年
|
海南愛麗斯生物科技有限公司
|
2026-07-14 | |
| 詢價 |
VIP4年
|
普善實業(yè)(陜西)有限公司
|
2026-06-26 | |
| ¥82.90 |
VIP14年
|
上海阿拉丁生化科技股份有限公司
|
2026-06-23 |